Chemclin

About:

Chemclin Biotech is a Chinese provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis.

Website: http://www.chemclin.com

Top Investors: Matrix Partners China, Legend Capital, WI Harper Group, SAIF Partners, Highlight Capital

Description:

Chemclin Biotech is a Chinese technical service provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. Chemclin Biotech’s service covers clinical inspection instruments, auxiliary reagents (chemiluminescence, biochemical, exemption), technical services, management and certification, independent medical laboratories, and more. The company is dedicated to the introduction of diagnostic products and services to the Chinese market.

Total Funding Amount:

$315M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

1999-01-01

Contact Email:

BD(AT)chemclin.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2018-08-01

IPO Status:

Public

© 2025 bioDAO.ai